PeptideDoc

PeptideDoc — Bayside, Queens · 4232 Francis Lewis Boulevard, Bayside, NY 11361

Physician-Guided Care

A Physician-Guided Approach to Weight Management

Tirzepatide may help support appetite regulation, metabolic health, and meaningful weight-management goals when prescribed as part of an individualized, physician-supervised treatment plan.

MD consultation required in the Bayside office.

Dual receptor action

GIP + GLP-1

GIP receptorGLP-1 receptor

*Prescription treatment is appropriate only for patients who meet clinical criteria and should be used under the supervision of a qualified healthcare professional.

Understanding Tirzepatide

Tirzepatide is an injectable prescription medication that represents a dual-acting approach to metabolic regulation. It works by activating two naturally occurring hormone receptors in the body: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).

Physiological Mechanisms

  • Appetite regulation and food intake control
  • Blood sugar regulation and insulin response
  • Promoting feelings of fullness (satiety)
  • Overall metabolic health support

Individualized Clinical Response

Response to treatment varies significantly between individuals. Medication is not a standalone fix, but rather one component of a comprehensive weight-management strategy that includes nutrition, physical activity, and lifestyle adjustments tailored by Dr. Maslavi.

Mechanism of Action

Dual GIP + GLP-1 Activation
Enhanced Appetite & Metabolic Signaling
Improved Satiety
Support for Weight Management

How Tirzepatide May Support Weight Management

Appetite & Satiety

May help patients feel fuller sooner and maintain satiety longer, making it easier to adhere to reduced-calorie nutrition plans.

Weight Management

Clinical studies have demonstrated meaningful reductions in body weight in appropriate patient populations. Individual results vary.

Metabolic Health

Acts directly on hormone pathways involved in glucose regulation, supporting glycemic control and broader metabolic function.

Long-Term Support

Weight care is a long-term journey. Medication is integrated alongside dietary changes, exercise, and ongoing medical oversight.

Your Treatment Should Be Personalized

Dr. Maslavi evaluates each patient individually before recommending prescription weight-management therapies. Medication is not automatically appropriate for every individual; thorough medical evaluation ensures safety and efficacy.

Comprehensive Patient Evaluation

  • Complete medical history and current medication review
  • Assessment of weight history and metabolic indicators
  • Screening for potential contraindications or precautions
  • Establishment of realistic, health-focused goals

Ongoing Medical Supervision

  • Regular monitoring of progress and tolerance
  • Gradual dose adjustments when clinically appropriate
  • Nutritional and behavioral guidance alignment
  • Long-term maintenance and wellness strategy

Your 4-Step Care Journey

1

Consultation

Discuss your health history, goals, current medications, and clinical eligibility with Dr. Maslavi.

2

Personalized Plan

Dr. Maslavi determines whether prescription medication is clinically appropriate for you.

3

Treatment

Follow the prescribed regimen alongside tailored nutrition and lifestyle recommendations.

4

Monitoring

Regular check-ins to monitor progress, manage side effects, and adjust dosage as needed.

Common Side Effects

Gastrointestinal symptoms are most common, particularly during initiation or dose escalation:

  • Nausea and vomiting
  • Diarrhea or constipation
  • Decreased appetite
  • Indigestion / abdominal discomfort

Serious Adverse Events

Serious complications are rare but require immediate medical attention:

  • Pancreatitis (inflammation of the pancreas)
  • Gallbladder disease or severe allergic reactions
  • Dehydration leading to kidney injury
  • Changes in vision (in patients with type 2 diabetes)

Important Boxed Warning & Contraindications:

Tirzepatide is contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also contraindicated in anyone with a known serious hypersensitivity/allergy to tirzepatide or any of its ingredients. Tell your healthcare provider if you experience a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath.

Sourced via FDA-registered 503B outsourcing facilities: Striker, Southlake, Kaduceus, Drug Crafters

What the Evidence Shows

Clinical studies have shown that tirzepatide can produce substantial reductions in body weight in certain patient populations. Individual results vary based on dose, adherence, nutrition, activity, and metabolic factors. Refer to official FDA prescribing information and Eli Lilly clinical trials for detailed data.

Mounjaro® vs. Tirzepatide Clarification

Tirzepatide is the active pharmaceutical ingredient. Mounjaro® is a brand name for tirzepatide, FDA-approved for improving glycemic control in adults with type 2 diabetes. Different tirzepatide products carry specific FDA-approved indications. Patients should use the exact medication prescribed by their physician.

Frequently Asked Questions

Is tirzepatide right for everyone?

No. Eligibility depends on individual health factors, medical history, current medications, and clinical treatment goals evaluated during your medical consultation.

How much weight can I expect to lose?

Results vary. While clinical trials demonstrated significant average weight reduction in specific study populations, individual outcomes cannot be guaranteed and depend on lifestyle factors and personal response.

Do I still need to diet and exercise?

Yes. Prescription treatment is designed to complement, not replace, a balanced nutritional plan, regular physical activity, and sustainable behavior modification.

Is Mounjaro® FDA approved specifically for weight loss?

Mounjaro® is FDA-approved to improve glycemic control in adults with type 2 diabetes. While weight reduction was observed as a benefit in clinical trials, tirzepatide formulations carry distinct FDA indications. Dr. Maslavi evaluates appropriate treatments based on your complete medical profile.

Bayside Only

Take a Guided Step Toward Your Health Goals

Schedule an individualized consultation with Dr. Maslavi to discuss your medical history and explore personalized weight management options.

Talk With Dr. Maslavi About Your Options

MD consultation required in the Bayside office.

Important Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice or establish a doctor-patient relationship. Tirzepatide is a prescription medication and is not appropriate for everyone. All treatment decisions must be made in consultation with a qualified healthcare provider after a complete evaluation of your medical history, health metrics, and individual goals. Saul F. Maslavi, MD — NPI 1134137383 | 503B Sourced via Striker, Southlake, Kaduceus, Drug Crafters